Multimodal Treatment Of Hemangiolymphangioma in a Pediatric Patient: Case Report and Literature Review.

Background: Hemangiolymphangioma is an uncommon benign lesion characterized by the simultaneous presence of both vascular and lymphatic vessels. It has been rarely reported, and its occurrence in the oral cavity is even rarer compared to other regions, with only 18 cases published in the English-language literature. In addition, there are doubts about the best approach.

A Clinicopathological Study of Marginal Gingival Leukoplakia.

Background: Marginal gingival leukoplakias are relatively uncommon and rarely discussed in the scientific literature. Studies suggest they are distinct from other leukoplakias due to aggressive behavior and a strong association with proliferative verrucous leukoplakia. This study aimed to evaluate the clinicopathological characteristics of patients diagnosed with marginal gingival lesions.

Histopathological risk assessment in multisite epithelial dysplasia: A meta-analysis.

Objective: Histopathological grading of oral epithelial dysplasia (OED) is the current standard for stratifying cancer progression risk but is associated with subjectivity and variability. This problem is not commonly seen regarding the grading of epithelial dysplasia in other sites. This systematic review aims to compare grading systems for oral, anal, penile, and cervical epithelial dysplasia to determine their predictive accuracy for recurrence and malignant transformation (MT) outcomes.

Risk and prevalence of oral cancer in patients with different types of lupus erythematosus: a systematic review and meta-analysis.

Objective: The objective of this study was to assess the risk and prevalence of oral cancer in patients with systemic lupus erythematosus (SLE) or discoid lupus erythematosus (DLE).

Study Design: The review included observational cohort and cross-sectional studies that investigated the incidence or prevalence of oral cancer in adults with confirmed diagnoses of SLE or DLE. Studies were selected based on predefined eligibility criteria, including the use of specific diagnostic criteria for SLE and DLE.